International Cannabis Weekly: 51

• Aurora Cannabis becomes first licensed supplier of medical cannabis to Malta.
• Clone transfer takes Spectrum a step closer to producing European-grown cannabis.
• [Video] Casa Verde & Imperial Brands invest €8.6 million in UK cannabis biotech firm.
• Growth of cannabis markets have been exceeding expectations.
• Tilray cannabis products will begin to carry drug company Sandoz’s name in Canada.
• Canopy CEO suggests the future of cannabis is not as a commodity.
• BlissCo signs letter of intent to export cannabis to Germany.
• The Hydroponics Company begins importing cannabis products from Denmark.
• InterCure becomes tenth cannabis company to be listed on the Tel Aviv Stock Exchange.
• Cannabis is disrupting Italian drinks market, while brewers enter the cannabis industry.
• The Green Organic Dutchman enters European market via Denmark.

• Luxembourg’s Chamber of Deputies unanimously pass bill to legalise medical cannabis.
• Introduction of Canadian Cannabis Act will severely effect European imports.
• Ireland’s Taoiseach confirms that cannabis decriminalisation is being considered.
• British MP Nick Hurd calls existing cannabis laws ‘not fit for purpose’.
• Lyon becomes second major French city home to a ‘cannabis light’ store.
• GW Pharmaceutical’s Epidiolex becomes first cannabis-based drug approved by FDA.
• Special licenses for medical cannabis could be available in UK ‘within weeks’.

• Cannabis may serve as a neuroprotectant and aid neurogenesis.
• Study suggests a majority of chronic pain patients are replacing opioids with cannabis.
• CBD therapy appears to reduce symptoms of autism in Israeli study.
• Scientists may have found a third cannabinoid receptor in humans.
• How can cannabis benefit people living with Alzheimer’s?
• Cannabis compound shown to improve memory function in ageing mice.

• Tilray seeks $100 million in NASDAQ filing.
• Sri Lanka legalises medical cannabis for domestic cultivation and exports.
• Together CEO expects to be producing cannabis in Africa by January.
• Jamaican science minister says country ‘must act quickly’ to develop cannabis industry.

Prohibition Partners is excited to announce the launch of ‘Medical Cannabis in Europe – The GMP Standards Guide’, in association with Orion GMP Solutions. The Guide is used by manufacturers and legislators to understand the complex network of regulations that will shape the European cannabis market.